MSAB: Continued investment for growth
January - June
- Net sales increased 1.6 percent to SEK 130.4 (128.3) million (-4 percent in local currencies).
- EBIT amounted to SEK -17.1 (3.8) million.
- The EBIT margin was -13.1 (3.0) percent.
- Profit after tax amounted to SEK -15.3 (5.7) million.
- Earnings per share amounted to SEK -0.83 (0.31).
- Cash flow from operating activities amounted to SEK -6.2 (-11.1) million.
- Cash and cash equivalents and short-term investments amounted to SEK 52.5 (80.4) million at the end of the period.
- Net sales increased 1.7 percent to SEK 64.1 (63.0) million (-4 percent in local currencies).
- EBIT amounted to SEK -11.4 (0.1) million.
- The EBIT margin was -17.8 (0.2) percent.
- Profit after tax amounted to SEK -10.8 (1.3) million.
- Earnings per share amounted to SEK -0.58 (0.07).
- Cash flow from operating activities amounted to SEK 0.7 (-11.4) million.
Comments from the CEO
Sales amounted to SEK 130.4 (128.3) million for the first six months of the year. EBIT came in at SEK -17.1 (3.8) million, the decline in profit resulting from a decrease in new sales, combined with continued investments within product development and marketing with the aim of generating future growth. For the second quarter, sales reached SEK 64.1 (63.0) million.
Growth for the first half of 2019 is not to my satisfaction. The market for mobile forensics carries significantly greater potential than what is visible in our numbers. Income from license renewals continues to grow, which demonstrates that our existing customers are satisfied with the systems they have invested in. My dissatisfaction lies primarily with new sales.
Our greatest growth potential lies in the decentralised solutions which we call Frontline. Decentralised solutions mean that police, who currently seize suspects’ mobile phones and send them elsewhere for analysis, can instead easily extract data themselves from the phones. In this way, they can quickly take advantage of important information, thereby solving and preventing crime more effectively. One of the reasons that new sales of these systems is lagging is that they entail a whole new way of working for the police. Changing ways of working takes time in large organisations. Nevertheless, the vast majority of customers realise the enormous benefits of decentralisation, but it takes time to decide where the responsibility for these solutions should lie.
I can also report that those customers that have invested in and have experience with our Frontline solutions are very satisfied. In my assessment, MSAB is the company that has delivered the greatest number of decentralised solutions world-wide. We have however seen a trend towards more aggressive price-setting from competitors to win these deals.
We have customers who have been using our systems for many years, and some customers extract data from up to 700 phones per day with XRY. This means that XRY handles extremely large amounts of information every day, and this makes an enormous difference in creating a safer and more secure society.
We continuously develop our product portfolio. Most recently, we released a new version of XRY, that extracts more data in a shorter time and with a significantly improved user experience. Besides offering a strong concept for extracting information from mobile phones, we even have tools for efficient analysis of data from mobile phones through our XAMN products. Thanks to our unique way of sorting data immediately as the mobile phone is being read, in combination with smart AI functions, our products can also analyse vast quantities of data in a short time. With high precision, we can present data relevant to the criminal investigation that the investigator is working on in the moment.
During the third quarter, the company will also carry out some process- and organizational changes in order to strengthen our product offering and intensify our marketing activities. The purpose of these changes is to increase growth and profitability of the company.
MSAB is a company on a market with all the prerequisites for growth and healthy profitability.
Stockholm, July 2019
Chief Executive Director
The information in this report is such that MSAB, Corporate ID number 556244-3050, is required to disclose in accordance with the EU’s Market Abuse Regulation. The information in this report was submitted for publication on 19 July, 2019 at 08:00 CEST through the offices of the contact person listed below.
Questions should be addressed to:
Chief Executive Officer Joel Bollö
Tel. +46 8 739 0270
MSAB in brief
MSAB is a world leader in mobile forensics technology with the aim of extracting and analysing data from confiscated mobile devices, mainly from mobile phones. The Company has its own sales offices and sales representatives in Europe, North America, South America, China, Australia, Singapore, Japan and Russia, and together with a number of distributors, covers most of the world. The proprietary products have become a de facto standard in the field and are used for securing evidence in more than 100 countries. These products are complemented by a wide range of training courses with the possibility of becoming certified in a forensically sound methodology. Customers are primarily law enforcement agencies, such as police, military and customs. MSAB is listed on NASDAQ Stockholm under the ticker symbol: MSAB B.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
PCI Biotech: Invitation to second quarter and first half 2019 results presentation20.8.2019 15:38:00 CEST | Press release
Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 28 August, 08:30am – 09:30am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo. The presentation will be held in English and if you wish to attend the presentation, please confirm with an e-mail to firstname.lastname@example.org. The presentation will also be a live webcast and can be accessed through www.pcibiotech.com. It will be possible to post questions through the webcast console. The interim report and the presentation will be available on www.newsweb.no and on the company's webpage, www.pcibiotech.com from 07:00am (CEST) on 28 August 2019. For further information, please contact: Ronny Skuggedal, CFO Email: email@example.com Mobile: +47 9400 5757 About PCI Biotech PCI Biotech is a biopharmaceutica
Regarding resignation of member of the Supervisory Board20.8.2019 15:30:00 CEST | Press release
We hereby inform that, T. Lukoševičius, a member of Supervisory Board of AB Klaipedos nafta (hereinafter – the Company) 20 August 2019 submitted a notice of resignation of members of Supervisory Board of the Company as of 3 September 2019 (this day is the last day of the mandate). It should be noted that, currently the Supervisory Board of the Company consists of 3 members, 2 of them are independent. After the resignation of T. Lukoševičius, the Ministry of Energy of the Republic of Lithuania will conduct the selection of new member of the Supervisory Board. The Supervisory Board is elected by the General Meeting of Shareholders for 4 years. If individual members of the Supervisory Board are elected, they shall be elected only until the end of the term of office of the current Supervisory Board. Jonas Lenkšas, Chief Financial Officer,+370 694 80594
SERSTECH AB: Boardmember Anna Werntoft resigns from the Board of Serstech20.8.2019 13:40:00 CEST | Press release
Anna Werntoft will leave the board of directors effective on the 30th of September. The reason for her resignation is that she enters a new operational position with terms that does not allow external assignments. Serstech wishes Anna all the best in her new position and would like to thank her for her contribution while being on the Serstech Board. The Serstech will consist of three Board members until the vacant position is filled. The search for a replacement has started and will be concluded before the next annual general meeting. For further information, please contact: Stefan Sandor, CEO, Serstech AB tel: +46 739 606067 email: firstname.lastname@example.org Thomas Pileby, Chairman of the Board, Serstech AB tel: +46 702 072643 email: email@example.com Company website: www.serstech.com The information was submitted for publication, through the agency of the contact person set out above at 13:40 CET on August 20, 2019. Certified advisor to Serstech is Västra Hamnen Corporate Finance AB, phone: 040-2
Nordic CEOs for a Sustainable Future seek to collaborate with Nordic governments on climate action and diversity in the workplace20.8.2019 13:31:00 CEST | Press release
Press Release 20 August 2019 Reykjavik, Iceland – The Nordic CEOs for a Sustainable Future , an alliance of the leaders of the Nordic region’s leading businesses, met today with the Prime Ministers of the five Nordic countries to discuss a collaborative approach to addressing sustainability challenges. The CEOs presented their vision for achieving the United Nations Sustainable Development Goals (SDGs) through greater public-private sector collaboration and the transition to purpose-driven business practices. The alliance will initially focus on climate action and diversity and inclusion in the workplace. The meetings formed part of the Nordic Council of Ministers’ session held in Reykjavik, Iceland, this week. Integrating the SDGs into business strategies The CEOs are committed to integrating the SDGs into their business activities and decision-making, incorporating sustainability into their own policies and across their value chains. Recognizing that the 2030 deadline for achieving t
SERSTECH AB: Serstech appoints new CFO20.8.2019 13:30:00 CEST | Press release
Serstech has a new CFO in Joakim Nyström. Joakim joined the Serstech team as Finance Manager in late 2018, working close to Thomas Pileby with the intention of later replacing him as CFO in a seamless way during 2019. Before joining the Serstech team, Joakim was a corporate relationship manager with Svenska Handelsbanken, a role at which he has spent the majority of his career since graduating with a Masters degree in international Business Administration and Economics from the University of Lund. Having spent many years in a mature and structured organisation, analysing company data and discussing how to successfully manage the organisation with its leaders, Joakim brings a diversity of insight into successful processes and structuring that Serstech gains from in its current state of expansion. Joakim has been acting CFO since Thomas Pileby took over as Chairman of the Board at the annual general meeting. Joakim assumes the CFO role as of today. For further information, please contact
Medtronic Reports First Quarter Financial Results20.8.2019 12:45:00 CEST | Press release
Revenue of $7.5 Billion Increased 1.5% Reported; Increased 3.5% Constant Currency GAAP Diluted EPS of $0.64; Non-GAAP Diluted EPS of $1.26 Company Raises FY20 EPS Guidance by 10 Cents DUBLIN, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2020, which ended July 26, 2019. The company reported first quarter worldwide revenue of $7.493 billion, an increase of 1.5 percent as reported or 3.5 percent on a constant currency basis, which adjusts for a $146 million negative impact from foreign currency. As reported, first quarter GAAP net income and diluted EPS were $864 million and $0.64, respectively. As detailed in the financial schedules included through the link at the end of this release, first quarter non-GAAP net income and non-GAAP diluted EPS were $1.703 billion and $1.26, respectively, increases of 6 percent and 8 percent, respectively. Adjusting for a negative 2 cent impact from foreign currency, firs